Average Co-Inventor Count = 12.58
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Morphic Therapeutic, Inc. (15 from 15 patents)
2. Ptc Therapeutics, Inc. (3 from 184 patents)
3. Hibercell, Inc. (3 from 10 patents)
4. The University of Texas System (1 from 5,463 patents)
5. Mmv Medicines for Malaria Venture (1 from 11 patents)
6. Petra Pharma Corporation (1 from 4 patents)
23 patents:
1. 12459942 - Inhibiting (α-v)(β-6) integrin
2. 12415796 - Inhibitors of (αv)(β6) integrin
3. 12221416 - Antagonists of human integrin α4β7
4. 12145935 - Inhibitors of (α-v)(β-6) integrin
5. 11919902 - Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
6. 11903936 - Anti-malarial agents
7. 11858941 - Heterocyclic and heteroaryl compounds for treating Huntington's disease
8. 11827621 - Inhibitors of (α-v)(β-6) integrin
9. 11795167 - Inhibitors of (α-v)(β-6) integrin
10. 11739087 - Inhibiting (α-v)(β-6) integrin
11. 11667651 - Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
12. 11649227 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
13. 11584763 - Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
14. 11370773 - Inhibiting human integrin (alpha-4) (beta-7)
15. 11174228 - Antagonists of human integrin (α4)(β7)